病死亡率的国家模式,1999-2023年:来自CDCWONDER数据库的见解
1Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.
The American surgeon
|December 23, 2025
概括
美国 Hernia 死亡人数有所增加,死亡率上升,种族/民族差异持续存在. 具体的型表现出不同的趋势,突出了针对性干预的必要性.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 外科手术的结果
背景情况:
- 是常见的疾病,但全国死亡率仍然存在.
- 包括COVID-19大流行在内的2023年间死亡的长期趋势和差异尚未完全理解.
研究的目的:
- 分析1999年至2023年间死亡率的国家趋势和差异.
- 检查年龄调整的死亡率 (AAMR) 和随时间的变化.
- 通过人口因素,地区,城市化和子亚型来确定死亡率的变化.
主要方法:
- 使用CDC WONDER数据库查看美国居民死亡的ICD-10代码K40-K46 (1999-2023).
- 计算的年龄调整死亡率 (AAMRs) 标准化为2000年美国人口.
- 采用结合点分析来确定年平均百分比变化 (AAPC) 和按性别,年龄,种族/种族,地区,城市化和子亚型分析子组.
主要成果:
- 病死亡总数增加了87.46% (每年从1396到2617).
- 总体AAMR从1.02上升到1.23 (AAPC +0.91%),在2019年后和2020-2021年期间观察到的增加.
- 种族/种族,地区,城市化和年龄的显著差异仍然存在; inguinal hernia死亡人数大幅增加 (+118.99%),而大腿 Hernia AAMR 则下降.
结论:
- 美国的死亡率呈现出越来越大的绝对负担,AMR的适度增加.
- 子亚型之间持续的差异和多样化的趋势需要对亚型进行意识监测.
- 诸如弹性选择能力和公平的紧急护理途径等策略对于减少可预防的死亡至关重要.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.0K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
470
相关概念视频
01:08Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
01:12Hazard Ratio
548
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
548